Topic Hub
3 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 3 of 3 clinical reviews.
Evidence-based guide to lisdexamfetamine dosing considerations for East Asian patients, covering CYP2D6 pharmacogenomics, body-weight corrections, and clinical monitoring.
Read clinical reviewEvidence-based review of how lisdexamfetamine (Vyvanse) efficacy and metabolism differ in South Asian populations, including pharmacogenomic factors, dosing considerations, and cardiovascular risk context.
Read clinical reviewHow South Asian genetics, cardiovascular risk thresholds, and CYP2D6 polymorphisms affect lisdexamfetamine (Vyvanse) safety, dosing, and monitoring.
Read clinical review